Curt Labelle

Curt LaBelle is currently the Managing Partner at AXA IM Global Health Private Equity, overseeing investments in companies developing therapeutics and diagnostics with global healthcare potential. With a strong background in business and medicine, Curt also serves on the boards of various healthcare companies, including Vedanta Biosciences, CXL Ophthalmics, Maternal Newborn Health Innovations, Ophirex, Inc., Z Optics, Atticus Medical, Revelation Biosciences Inc., and Atomo Diagnostics. Curt holds an MBA from Columbia Business School, an MD from Columbia University Vagelos College of Physicians and Surgeons, and a Bachelor’s Degree in Economics from Brigham Young University.